291 related articles for article (PubMed ID: 11687117)
1. House dust mite avoidance measures for perennial allergic rhinitis.
Sheikh A; Hurwitz B
Cochrane Database Syst Rev; 2001; (4):CD001563. PubMed ID: 11687117
[TBL] [Abstract][Full Text] [Related]
2. House dust mite avoidance measures for perennial allergic rhinitis.
Sheikh A; Hurwitz B; Shehata Y
Cochrane Database Syst Rev; 2007 Jan; (1):CD001563. PubMed ID: 17253461
[TBL] [Abstract][Full Text] [Related]
3. House dust mite avoidance measures for perennial allergic rhinitis.
Sheikh A; Hurwitz B; Nurmatov U; van Schayck CP
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD001563. PubMed ID: 20614426
[TBL] [Abstract][Full Text] [Related]
4. House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review.
Nurmatov U; van Schayck CP; Hurwitz B; Sheikh A
Allergy; 2012 Feb; 67(2):158-65. PubMed ID: 22103686
[TBL] [Abstract][Full Text] [Related]
5. House dust mite avoidance measures for perennial allergic rhinitis: a systematic review of efficacy.
Sheikh A; Hurwitz B
Br J Gen Pract; 2003 Apr; 53(489):318-22. PubMed ID: 12879834
[TBL] [Abstract][Full Text] [Related]
6. House dust mite reduction and avoidance measures for treating eczema.
Nankervis H; Pynn EV; Boyle RJ; Rushton L; Williams HC; Hewson DM; Platts-Mills T
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008426. PubMed ID: 25598014
[TBL] [Abstract][Full Text] [Related]
7. House dust mite control measures for asthma.
Gøtzsche PC; Johansen HK; Burr ML; Hammarquist C
Cochrane Database Syst Rev; 2001; (3):CD001187. PubMed ID: 11686981
[TBL] [Abstract][Full Text] [Related]
8. House dust mite control measures for asthma.
Gøtzsche PC; Johansen HK; Hammarquist C; Burr ML
Cochrane Database Syst Rev; 2001; (2):CD001187. PubMed ID: 11405979
[TBL] [Abstract][Full Text] [Related]
9. Correlation of environmental mite levels and the symptoms of allergic rhinitis regarding the efficacy of preventive education.
Cingi C; Cakli H; Miman O; Altin F; Aycan O; Atambay M; Daldal N
Allergol Immunopathol (Madr); 2007; 35(6):243-7. PubMed ID: 18047815
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
11. House dust mite control measures for asthma.
Hammarquist C; Burr ML; Gotzsche PC
Cochrane Database Syst Rev; 2000; (2):CD001187. PubMed ID: 10796618
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of impermeable covers for bedding in patients with allergic rhinitis.
Terreehorst I; Hak E; Oosting AJ; Tempels-Pavlica Z; de Monchy JG; Bruijnzeel-Koomen CA; Aalberse RC; Gerth van Wijk R
N Engl J Med; 2003 Jul; 349(3):237-46. PubMed ID: 12867607
[TBL] [Abstract][Full Text] [Related]
13. House dust mite control measures for asthma.
Gøtzsche PC; Johansen HK; Schmidt LM; Burr ML
Cochrane Database Syst Rev; 2004 Oct; (4):CD001187. PubMed ID: 15495009
[TBL] [Abstract][Full Text] [Related]
14. House dust mite control measures for asthma.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD001187. PubMed ID: 18425868
[TBL] [Abstract][Full Text] [Related]
15. House dust mite avoidance--the right way to go forward.
Kniest FM; Van Bronswijk JM
Clin Exp Allergy; 1992 May; 22(5):589-90. PubMed ID: 1445575
[No Abstract] [Full Text] [Related]
16. Research on allergic rhinitis improvement in asthmatic children after dust mite exposure reduction: a randomized, double-blind, cross-placebo study protocol.
Chen M; Wu Y; Yuan S; Chen J; Li L; Wu J; Zhang J; Yin Y
Trials; 2020 Jul; 21(1):686. PubMed ID: 32727603
[TBL] [Abstract][Full Text] [Related]
17. Continuous avoidance measures with or without acaricide in dust mite-allergic asthmatic children.
Bahir A; Goldberg A; Mekori YA; Confino-Cohen R; Morag H; Rosen Y; Monakir D; Rigler S; Cohen AH; Horev Z; Noviski N; Mandelberg A
Ann Allergy Asthma Immunol; 1997 May; 78(5):506-12. PubMed ID: 9164365
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis.
Terreehorst I; Oosting AJ; Tempels-Pavlica Z; de Monchy JG; Bruijnzeel-Koomen CA; Hak E; van Wijk RG
Clin Exp Allergy; 2002 Aug; 32(8):1160-5. PubMed ID: 12190652
[TBL] [Abstract][Full Text] [Related]
19. Environmental controls in reducing house dust mites and nasal symptoms in patients with allergic rhinitis.
Moon JS; Choi SO
Yonsei Med J; 1999 Jun; 40(3):238-43. PubMed ID: 10412335
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
